1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TMEM206 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA ATXN7L3B CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA SNRPA CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA UGT3A2 CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA BLMH CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA ATP5H CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA C16orf95 CTRPv2 pan-cancer AAC -0.13 4e-05
mRNA KCMF1 CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA DLX5 CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA LINC00116 CTRPv2 pan-cancer AAC -0.13 4e-05
Download CSV